Sorrento Therapeutics Inc. (SRNE) Social Stream
SORRENTO THERAPEUTICS INC (SRNE) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SRNE.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-28 | 3 | $35 | $19 | $26.666 | $0.307 | 8585.99% |
| 2022-01-04 | 3 | $35 | $18 | $26.333 | $0.307 | 8477.52% |
| 2022-02-18 | 2 | $26 | $18 | $22 | $0.307 | 7066.12% |
| 2022-03-25 | 2 | $20 | $18 | $19 | $0.307 | 6088.93% |
| 2022-05-09 | 2 | $20 | $16 | $18 | $0.307 | 5763.19% |
| 2022-09-27 | 2 | $20 | $5 | $12.5 | $0.307 | 3971.66% |
| 2023-01-05 | 3 | $20 | $5 | $10 | $0.307 | 3157.33% |
| 2023-01-31 | 2 | $13 | $5 | $9 | $0.307 | 2831.6% |
The Trend in the Analyst Price Target
Over the past 14 months, SRNE's average price target has gone down $17.67.
SRNE reports an average of 758.44% for its upside potential over the past 45 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-25 | 2 | 20 | 18 | 19.000 | 2.420 | 685.12% |
| 2022-08-18 | 2 | 20 | 5 | 12.500 | 2.050 | 509.76% |
| 2022-09-27 | 2 | 20 | 5 | 12.500 | 1.550 | 706.45% |
| 2022-11-02 | 3 | 20 | 5 | 10.000 | 1.480 | 575.68% |
| 2023-01-31 | 3 | 13 | 5 | 7.666 | 0.959 | 699.37% |
SRNE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 34 months, SRNE's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SRNE as an investment opportunity.
- In the context of all US stocks, SORRENTO THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 996.43% of them.
- In terms of how SORRENTO THERAPEUTICS INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 45.35% of that group.
- In the context of stocks in the mid market cap category, SORRENTO THERAPEUTICS INC's variance in analysts' estimates is lower than -561.49% of them.
- In the context of stocks in the mid market cap category, SORRENTO THERAPEUTICS INC's average analyst price target is higher than 197.89% of them.
Stocks similar to SORRENTO THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MESO, PLX, and EDIT.
View All Top Stocks by Price Target
Is SRNE a Buy, Hold or Sell? See the POWR Ratings now!